Prudential Financial
MRNA icon

Prudential Financial’s Moderna MRNA Stock Holding History

Prudential Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
169,201
-1,697
-1% -$87.8K 0.01% 628
2026
Q1 		$8.68M Buy
170,898
+320
+0.2% +$14.9K 0.01% 683
2025
Q4 		$5.03M Sell
170,578
-23,139
-12% -$629K 0.01% 909
2025
Q3 		$5M Sell
193,717
-2,686
-1% -$74.9K 0.01% 941
2025
Q2 		$5.42M Buy
196,403
+16,174
+9% +$426K 0.01% 873
2025
Q1 		$6.15M Sell
180,229
-900
-0.5% -$31.9K 0.01% 757
2024
Q4 		$7.76M Sell
181,129
-24,663
-12% -$1.18M 0.01% 706
2024
Q3 		$13.8M Sell
205,792
-5,231
-2% -$480K 0.02% 561
2024
Q2 		$25.1M Sell
211,023
-27,186
-11% -$3.44M 0.04% 358
2024
Q1 		$25.4M Sell
238,209
-3,701
-2% -$373K 0.04% 383
2023
Q4 		$22.8M Sell
241,910
-47,405
-16% -$3.99M 0.03% 411
2023
Q3 		$29.9M Sell
289,315
-12,423
-4% -$1.39M 0.05% 341
2023
Q2 		$36.7M Sell
301,738
-10,863
-3% -$1.45M 0.05% 307
2023
Q1 		$47.3M Buy
312,601
+16,154
+5% +$2.66M 0.07% 240
2022
Q4 		$53.2M Sell
296,447
-354,102
-54% -$57.9M 0.09% 217
2022
Q3 		$76.8M Buy
650,549
+85,251
+15% +$12.9M 0.13% 156
2022
Q2 		$80.7M Buy
565,298
+227,585
+67% +$32.5M 0.13% 162
2022
Q1 		$58.2M Buy
337,713
+34,144
+11% +$5.75M 0.08% 254
2021
Q4 		$82.9M Sell
303,569
-22,605
-7% -$6.61M 0.1% 199
2021
Q3 		$135M Buy
326,174
+158,099
+94% +$58.3M 0.19% 116
2021
Q2 		$39.5M Buy
168,075
+126,474
+304% +$22.6M 0.05% 326
2021
Q1 		$5.45M Buy
41,601
+30,461
+273% +$4.41M 0.01% 986
2020
Q4 		$1.16M Sell
11,140
-390
-3% -$39.5K ﹤0.01% 1677
2020
Q3 		$816K Buy
11,530
+120
+1% +$8.37K ﹤0.01% 1738
2020
Q2 		$733K Buy
11,410
+1,460
+15% +$80K ﹤0.01% 1773
2020
Q1 		$298K Sell
9,950
-850
-8% -$19.6K ﹤0.01% 2065
2019
Q4 		$211K Buy
+10,800
New +$192K ﹤0.01% 2323

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Prudential Financial's MRNA Position: Q2 2026 in Review

Prudential Financial reduced its Moderna (MRNA) stake by 0.99% in Q2 2026, selling an estimated $87.8K and leaving 169,201 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #628.

Prudential Financial first reported a position in MRNA in Q4 2019 and has held it in 27 quarters since. The position peaked at $135M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Prudential Financial held 169,201 shares of Moderna worth $11.8M as of Q2 2026.
  • Prudential Financial sold 1,697 Moderna shares in Q2 2026, an estimated $87.8K.
  • Moderna made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #628 holding.
  • Prudential Financial first reported a position in Moderna in Q4 2019 and has held it in 27 quarters since.
  • Prudential Financial's Moderna position peaked at $135M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.